Singapore markets closed

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
23.57-1.20 (-4.84%)
At close: 04:00PM EDT
23.60 +0.03 (+0.13%)
After hours: 07:12PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-460,901
-479,449
-654,588
-405,670
-253,783
-
Depreciation & amortisation
43,248
42,881
35,962
22,271
16,065
-
Deferred income taxes
-1,597
-
-
0
0
-1,597
Stock-based compensation
95,534
90,759
94,685
151,449
144,113
-
Change in working capital
43,503
53,840
61,564
-40,468
-47,665
-
Accounts receivable
249
8,378
375
-44,353
-5,463
-
Inventory
-16,517
-10,350
-20,926
-7,957
-7,535
-
Accounts payable
-
-
60,328
8,638
-7,859
4,341
Other working capital
-300,714
-345,461
-386,924
-284,052
-157,986
-
Other non-cash items
32,435
31,202
135,265
29,652
18,676
-
Net cash provided by operating activities
-280,818
-324,975
-309,463
-209,017
-103,927
-
Cash flows from investing activities
Investments in property, plant and equipment
-19,896
-20,486
-77,461
-75,035
-54,059
-
Acquisitions, net
-7,328
-
-
0
0
-7,328
Purchases of investments
-572,243
-635,495
-327,723
-940,230
-1,125,575
-
Sales/maturities of investments
1,301,700
1,494,700
555,000
952,110
562,548
-
Other investing activities
-68
1,531
-
-
-
-68
Net cash used for investing activities
711,092
840,250
149,816
-63,155
-617,086
-
Cash flows from financing activities
Debt repayment
-
-
-71
-146
-174
-438
Common stock issued
-
493,116
0
0
355,730
-
Common stock repurchased
-723
-
-
-
-
0
Other financing activities
-26,576
-26,300
-201,034
-84,689
-94,622
-
Net cash used provided by (used for) financing activities
477,155
477,375
-189,093
-66,824
1,410,307
-
Net change in cash
905,543
991,739
-350,340
-340,689
689,749
-
Cash at beginning of period
223,714
141,948
492,288
832,977
143,228
-
Cash at end of period
1,131,143
1,133,687
141,948
492,288
832,977
-
Free cash flow
Operating cash flow
-280,818
-324,975
-309,463
-209,017
-103,927
-
Capital expenditure
-19,896
-20,486
-77,461
-75,035
-54,059
-
Free cash flow
-300,714
-345,461
-386,924
-284,052
-157,986
-